- Release Date: 25/02/15 10:06
- Summary: BUYBACK: CVT: Supplier Group Share Scheme - Listing Rule 7.6.2
- Price Sensitive: No
- Download Document 3.08KB
CVT 25/02/2015 10:06 BUYBACK NOT PRICE SENSITIVE REL: 1006 HRS Comvita Limited BUYBACK: CVT: Supplier Group Share Scheme - Listing Rule 7.6.2 Comvita Limited (NZX:CVT) will enhance its security of supply of Manuka honey through the introduction of a share scheme that will reward its largest and most loyal beekeeper honey suppliers who commit to long term supply agreements with Comvita. Comvita CEO Brett Hewlett said, "The scheme will provide a way for suppliers of Manuka honey to participate in the value add that Comvita is able to achieve as a business. To enact the scheme, Comvita will purchase on the NZX up to 600,000 of its ordinary shares between now and 29 January 2016. The buying back of already issued shares through the market will not dilute earnings per share for existing Comvita shareholders. Honey suppliers entering into long term contracts with Comvita will be able to participate in the dividend flow and capital appreciation in the Comvita shares through this new innovative scheme which will be introduced to beekeepers progressively over the next few months." Comvita therefore proposes to acquire its own equity securities by offers made through NZX's order matching market as follows: Offer date: The maximum period during which offers will be made is from and including 3 March 2015 (being three clear business days after the date of this Notice) to 29 January 2016. Equity securities to be acquired: The equity securities to be acquired are up to 600,000 ordinary shares, being approximately 1.50% of Comvita's total ordinary shares. #End# For further information or queries: Comvita CEO, Brett Hewlett, 021 740 160 Comvita Chairman, Neil Craig, 021 731 509 Comvita Communications Manager, Julie Chadwick, 021 510 693 Background information About Comvita (www.comvita.com) Comvita (NZX:CVT) is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research. We are the world leaders in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range. We have approximately 50% of honey supply under direct ownership or control, with the balance of supply from long term contractual and partnership arrangements. Comvita pioneered the development and use of medical grade Manuka honey and was the first to receive FDA approval (2007). We partner with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global licensee for Medihoney specialist wound care products, which are used in hospitals and medical centres around the world. Comvita's freshly picked Olive Leaf Extract is grown, harvested, extracted and bottled at the world's largest specialised olive leaf grove, with over one million olive trees. Comvita sells into more than 18 countries through a network of our own branded retail locations, online (nine country specific e-commerce websites) and third-party outlets. We have over 450 staff located in New Zealand, Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the USA. End CA:00261118 For:CVT Type:BUYBACK Time:2015-02-25 10:06:48
- Forums
- NZX - By Stock
- Ann: BUYBACK: CVT: Supplier Group Share Scheme - Listing Rule 7.6.2
Ann: BUYBACK: CVT: Supplier Group Share Scheme - Listing Rule...
Featured News
Add CVT (NZSX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online